On 31 March 2017, WHO for the first time prequalified a generic active pharmaceutical ingredient (API) for hepatitis C – sofosbuvir. Sofosbuvir is an essential ingredient for new, highly effective medicines to treat hepatitis C called direct active antivirals (DAAs). The prequalified product’s manufacturer is ...

The starting point for this guideline is the point at which a woman has learnt that she is living with HIV, and it therefore covers key issues for providing comprehensive sexual and reproductive health and rights-related services and support for women living with HIV. As ...

A new report from Public Citizen, the US-based consumer rights advocacy group, shows that the 20 largest pharmaceutical corporations are spending significantly less on research and development of new medicines than they are making in profits. The report shows that, on average for these top companies, ...

To end the TB epidemic, Ukraine has only one recipe – to implement quality people-centered TB care! This statement was made by Andriy Klepikov, Executive Director of the Alliance for Public Health at the press conference to mark World Tuberculosis Day. “Within its pilot projects supported ...

To mark World TB Day, 24 March 2017, the International Journal of Infectious Diseases published a special issue on TB. It highlights the Advances, Challenges and Opportunities in the ‘End TB’ Era through publishing 42 articles by a distinguished global authorship. The series of articles review progress ...

More than a third of HIV patients develop oral conditions from immune systems compromised by the virus and its treatment, according to the National Institutes of Health (NIH) While advances in HIV treatment have dramatically improved patient lifespans and quality of life, nagging side effects remain; ...

Neither the government nor CSOs have taken up the services previously supported by the Global Fund In January 2017, the Ministry of Finance of the Russian Federation rejected a request to allocate $1.2 billion over four years for the response to HIV, citing “a lack of ...

An international group of researchers involved in the ANRS 12174 randomised controlled trial of pre-exposure prophylaxis (PrEP) for infants say that it is high time we started giving PrEP to all breastfed babies of HIV-positive mothers in countries where the likelihood of transmission via breastfeeding ...

The FDA approved AZT in a record 20 months, a move that remains controversial today. HIV was first reported in 1981, but it wasn’t until six years later—in March 1987—that a drug to fight the virus was approved by the Food and Drug Administration (FDA). On ...

The AIDS response in Africa has come a long way and the continent is seeing results in many areas, including the dramatic reduction in the number of babies being born with HIV and an equally dramatic increase in access to HIV treatment. Nevertheless, inequalities in ...

The recording from the Ageing with HIV webinar held on 30 March 2017 is now available online:https://www.ageingwithhiv.com/webinars. The webinar is presented by four young persons who attended the Phase 2 conference ‘New challenges and unmet needs of children and adolescents living and ageing with HIV/AIDS’, organised in Bucharest, Romania, in  ...

ECUO team is pleased to present free online access to Community Regional Action Plan for Enhancing Sustainable Access to Quality and Continuous HIV Care for All Who Need It in Eastern Europe and Central Asia in 2017-2020 (Regional Plan). The developed Regional Plan is a ...

Central Asia and the Russian Federation face a major intra-regional migration flow, home, as it is, to one of the largest labor migration corridors in the world, with hundreds of thousands of migrant workers moving from Central Asian countries to the Russian Federation and to ...

A group of 18 of UNAIDS’ top donors have published a report highlighting UNAIDS’ unique value to the communities it serves and its partners and key stakeholders. The assessment, carried out by the Multilateral Organisation Performance Assessment Network (MOPAN), which was set up to monitor ...

High drug pricing for interferon-free direct acting antiviral regimens (up to US$93 000 per 12 week course) has limited broad implementation in the vast majority of settings, with restrictions based on liver disease stage generally introduced to reduce budget impact. Other restrictions, including those based on ...

The Lancet HIV is an exclusively online journal dedicated to publishing original research that advocates change in, or illuminates, HIV clinical practice. It publishes translational, epidemiological, clinical, operational, and implementation studies. The April 2017 issue is available here. Source

WHO/Europe has launched the third in a series of publications providing in-depth analyses of health situations in Member States. Focused on the Republic of Moldova, the report reveals a health situation that has improved significantly in the last decade but still faces considerable challenges. The report, ...

Implant could offer long-acting, removable form of prevention not currently available Chapel Hill, NC – Researchers at the University of North Carolina at Chapel Hill have received a three-year, $1.8 million grant from the National Institutes of Health to develop a new implantable drug delivery system ...